Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026

-First scientific presentation of the Emperor Drive System architecture to the biomedical engineering community-

TUCSON, Ariz., July 27, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSEAmerican:PMI) ("Picard" or the "Company"), parent company of SynCardia Systems LLC, maker of the world's first and only total artificial heart approved by the U.S. Food and Drug Administration (FDA) and Health Canada, today announced that Taha Hasekioglu, Director, Office of the COO & Emperor Program Lead, will present new engineering insights into the Company’s next-generation Emperor Total Artificial Heart (Emperor TAH) system during the 48th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC 2026), taking place July 26–30, 2026, in Toronto, Canada.